Cargando…
Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
High grade uterine sarcoma and recurrent endometrial carcinoma are aggressive cancers with limited treatment options, resulting in a poor prognosis. In this research we focused in the first place on the detection of a highly immunogenic tumour-associated antigen Wilms’ tumour gene 1 (WT1) in uterine...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Universa Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987486/ https://www.ncbi.nlm.nih.gov/pubmed/24753854 |